Jeffrey S. Dover MD

Appearances

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
Date
November 21, 2024
DaxibotulinumtoxinA-lanm for injection (DAXI), a novel botulinum toxin type A formulation, contains a purified 150-kD core neurotoxin (daxibotulinumtoxinA) and proprietary stabilizing peptide (RTP004), and is approved for glabellar line treatment…
Speakers
Shannon Humphrey, MD
Jeffrey S. Dover, MD
Ronald R. Bowsher, PhD
Amanda Clancy, MSc
Yan Liu, MSc
Gregg Prawdzik, PhD
Conor J. Gallagher, PhD